Loading ARQT...
Arcutis Biotherapeutics Inc.ARQTAs of 31 July 2026
−9
PositiveNegative
Equilibrium
Emotion
Is Arcutis Biotherapeutics Inc. oversold, or is the crowd euphoric?
A read on the market's emotion around Arcutis Biotherapeutics Inc. (ARQT): where sentiment sits between capitulation and euphoria, measured against the stock's own history so heavily covered and quieter names read on the same scale. Information, not advice.
Arcutis Biotherapeutics Inc.ARQTLast 5 years
V—E—F—A—
——
ARQT priceasymmetryquant.com